Dr. Paul Aanderud, D.O
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,303 | 287 | 90.7% |
| Education | $541.60 | 11 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,153 | 85 | $0 (2024) |
| Janssen Biotech, Inc. | $868.47 | 38 | $0 (2023) |
| Lilly USA, LLC | $532.18 | 32 | $0 (2024) |
| Merz North America, Inc. | $492.26 | 5 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $419.66 | 43 | $0 (2022) |
| PFIZER INC. | $345.78 | 20 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $308.57 | 7 | $0 (2024) |
| GENZYME CORPORATION | $300.26 | 9 | $0 (2023) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $280.40 | 11 | $0 (2020) |
| Biofrontera Inc. | $262.89 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $278.13 | 8 | Regeneron Healthcare Solutions, Inc. ($117.88) |
| 2023 | $626.24 | 36 | Janssen Biotech, Inc. ($212.98) |
| 2022 | $344.75 | 13 | Lilly USA, LLC ($145.89) |
| 2021 | $193.30 | 4 | Regeneron Healthcare Solutions, Inc. ($133.92) |
| 2020 | $234.75 | 20 | AbbVie Inc. ($128.08) |
| 2019 | $1,536 | 80 | AbbVie, Inc. ($400.47) |
| 2018 | $1,657 | 82 | Merz North America, Inc. ($297.41) |
| 2017 | $974.15 | 55 | Janssen Biotech, Inc. ($232.91) |
All Payment Transactions
298 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Immunology | ||||||
| 10/23/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: DERMATOLOGY | ||||||
| 09/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $98.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/28/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Immunology | ||||||
| 05/29/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Immunology | ||||||
| 05/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/15/2024 | Elekta, Inc. | ELEKTA MEDICAL LINEAR ACCELERATOR (Device) | Food and Beverage | In-kind items and services | $50.05 | General |
| Category: LINAC SOLUTIONS (LINAC) | ||||||
| 02/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/06/2023 | Galderma Laboratories, L.P. | ORACEA (Drug), EPSOLAY, AKLIEF | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: ROSACEA | ||||||
| 11/21/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Immunology | ||||||
| 11/07/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/02/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Immunology | ||||||
| 10/18/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $59.99 | General |
| Category: Immunology | ||||||
| 10/10/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/03/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Immunology | ||||||
| 09/28/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $4.59 | General |
| 09/27/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/07/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $48.09 | General |
| Category: Immunology | ||||||
| 08/29/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $32.52 | General |
| 08/25/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/24/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: DERMATOLOGY | ||||||
| 07/26/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $24.53 | General |
| 07/10/2023 | Sun Pharmaceutical Industries Inc. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Dermatology | ||||||
| 06/28/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.53 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,102 | 3,659 | $431,157 | $135,433 |
| 2022 | 17 | 2,307 | 3,969 | $533,482 | $149,196 |
| 2021 | 19 | 2,705 | 4,872 | $575,568 | $185,267 |
| 2020 | 18 | 2,453 | 4,581 | $544,673 | $160,566 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 581 | 685 | $134,570 | $42,219 | 31.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 277 | 301 | $76,948 | $25,296 | 32.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 412 | 508 | $75,767 | $21,187 | 28.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 125 | 133 | $29,950 | $9,376 | 31.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 312 | 1,559 | $24,157 | $8,680 | 35.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 110 | 110 | $26,870 | $8,272 | 30.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 130 | 142 | $17,638 | $5,679 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 32 | $8,938 | $3,027 | 33.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 12 | 13 | $9,506 | $2,938 | 30.9% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 16 | 17 | $5,350 | $2,160 | 40.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 15 | $5,996 | $2,096 | 35.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 24 | 24 | $3,816 | $1,184 | 31.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 12 | 13 | $4,329 | $1,025 | 23.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 15 | 22 | $2,354 | $914.85 | 38.9% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 11 | $2,415 | $753.78 | 31.2% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 16 | $2,042 | $589.27 | 28.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 58 | $510.64 | $35.45 | 6.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 606 | 730 | $154,145 | $44,455 | 28.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 307 | 338 | $94,778 | $27,692 | 29.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 444 | 537 | $89,493 | $20,843 | 23.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 161 | 170 | $43,620 | $12,861 | 29.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 154 | 154 | $41,118 | $10,617 | 25.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 324 | 1,651 | $27,551 | $9,011 | 32.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 145 | 161 | $21,256 | $6,387 | 30.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 18 | 18 | $13,515 | $4,240 | 31.4% |
About Dr. Paul Aanderud, D.O
Dr. Paul Aanderud, D.O is a Student in an Organized Health Care Education/Training Program healthcare provider based in Clackamas, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2009. The National Provider Identifier (NPI) number assigned to this provider is 1255569273.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Aanderud, D.O has received a total of $5,844 in payments from pharmaceutical and medical device companies, with $278.13 received in 2024. These payments were reported across 298 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($5,303).
As a Medicare-enrolled provider, Aanderud has provided services to 9,567 Medicare beneficiaries, totaling 17,081 services with total Medicare billing of $630,462. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Dermatology
- Location Clackamas, OR
- Active Since 06/29/2009
- Last Updated 05/08/2013
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255569273
Products in Payments
- Humira (Biological) $551.29
- TALTZ (Drug) $526.54
- COSENTYX (Biological) $403.33
- Tremfya (Drug) $374.54
- DUPIXENT (Biological) $326.51
- EUCRISA (Drug) $289.72
- TREMFYA (Drug) $232.83
- Ameluz (Drug) $231.97
- STELARA (Biological) $188.96
- Skyrizi (Biological) $146.01
- BRYHALI (Drug) $128.63
- ATOPIC DERMATITIS - DISEASE (Drug) $119.37
- BOTOX (Biological) $111.88
- SKYRIZI (Biological) $110.84
- EPIDUO FORTE (Drug) $90.59
- Cimzia (Drug) $82.28
- REMICADE (Biological) $72.14
- DERMATITIS - DISEASE (Drug) $68.41
- HUMIRA (Biological) $66.58
- DUPIXENT (Drug) $64.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Clackamas
Ashtin Wilhelmstoetter, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $5,390
Aleen Lee, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $1,569
Dr. Ben Bryant, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $1,470
Stephen Proctor
Student in an Organized Health Care Education/Training Program — Payments: $1,256
Dr. Stephanie Toder, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $860.85
Thomas Nguyen
Student in an Organized Health Care Education/Training Program — Payments: $846.91